Thomas Girton, NP
Adult Health · Roanoke, VANPI 1174287072
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,422 of the $7,078 with a category attached, or 62.5%. 21 manufacturers reported payments, led by Medtronic at 36.6% of the total. Reporting peaked in 2024 at $4,548 and has fallen 69.6% since, to $1,384 in 2025. Among adult health clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $70.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Edwards Lifesciences$718
- Novartis$250
- Ancora Heart, Inc.$202
- E.r. Squibb & Sons, L.L.C.$176
- plus $1K from 15 others
What the payments were for
- Travel & lodging$2,65638%
- Food & beverage$4,42262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 19 | $2,591 |
| Boston Scientific | 17 | $1,951 |
| Edwards Lifesciences | 6 | $718 |
| Novartis | 14 | $250 |
| Ancora Heart, Inc. | 2 | $202 |
| E.r. Squibb & Sons, L.L.C. | 7 | $176 |
| Abbott | 1 | $136 |
| Novo Nordisk | 2 | $134 |
| W. L. Gore & Associates, Inc. | 1 | $132 |
| Johnson & Johnson | 6 | $112 |
| Cardiac Dimensions, Inc. | 1 | $110 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $103 |
| Merck | 5 | $99 |
| Philips North America LLC | 3 | $93 |
| Amgen | 4 | $66 |
| AstraZeneca | 2 | $52 |
| Lexicon Pharmaceuticals, Inc. | 2 | $46 |
| Boehringer Ingelheim | 2 | $35 |
| Pfizer | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Penumbra, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$1,273
- COREVALVE EVOLUT R$1,261
- APOLLOTM$861
- WATCHMAN Access System$381
- AccuCinch$176
- SAPIEN 3 Ultra RESILIA$160
- TRICLIP$136
- EVOQUE$133
- GORE CARDIOFORM Septal Occluder$132
How this compares
$7,078 in reported general payments places this provider in the 90th percentile of 368 adult health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $68,257 |
| EntrestoSacubitril/Valsartan | 26 | $21,239 |
| BrilintaTicagrelor | 15 | $12,938 |
| XareltoRivaroxaban | 12 | $11,100 |
| FarxigaDapagliflozin Propanediol | 12 | $6,596 |
| Ranolazine ErRanolazine | 25 | $2,989 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,342 |
| Metoprolol Succinate | 59 | $860 |
| Lisinopril | 55 | $608 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $459 |
| Potassium Chloride | 24 | $439 |
| Bumetanide | 13 | $414 |
| Atorvastatin Calcium | 53 | $399 |
| Carvedilol | 44 | $328 |
| Metoprolol Tartrate | 56 | $316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $33 | $68,25757 claims |
| NovartisEntresto | $250 | $21,23926 claims |
| AstraZenecaBrilinta, Farxiga | $52 | $19,53427 claims |
| Johnson & JohnsonXarelto | $112 | $11,10012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 368 adult health providers in Virginia.
Other adult health in Roanoke
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Chelsea KoskovichFredericksburg$34K
- Brittany BrownLynchburg$14K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
- Amy WenzelMechanicsville$11K
- Robert GrossmanDanville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.